Interestingly, alveolar macrophages in OVA-induced airway inflammation, but not TH17 cells, are able to produce IL-17 through the up-regulation of chemotactic factors that increase mast cell trafficking while administration of IL-17 neutralizing antibody can suppress inflammatory cell recruitment [49]. The gene discussed is IL17A; the disease is inflammation.